Tecentriq

Made by

• Chugai (Roche)

Active Ingredient

Atezolizumab (genetical recombination)

Prospectus

Approval date

2018/1/19

Treats

• Breast cancer
• Small cell lung cancer
• Hepatocellular carcinoma, Liver cancer
• Non-small cell lung cancer

Dosages

• TECENTRIQ for Intravenous Infusion - 448853円／瓶

• TECENTRIQ for Intravenous Infusion - 563917円／瓶